Page 267 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis
P. 267

In: The Vasculitides, Volume 1               ISBN: 978-1-63463-110-5
Editors: David S. Younger       © 2015 Nova Science Publishers, Inc.

                                                                    Chapter 13

     Systemic Vasculitis and the Lung

 Christian Pagnoux, M.D., M.P.H.?1 and Gerard P. Cox, M.D., M.B.2

            1Mount Sinai Hospital, Division of Rheumatology – Vasculitis clinic,
                                      Toronto, Ontario, Canada

          2Division of Respirology, McMaster University, St. Joseph's Healthcare,
                                     Hamilton, Ontario, Canada

                                   Abstract

          The lungs are affected by systemic vasculitides with differing frequency,
     characteristics, and severity, depending on the specific vasculitis syndrome. Alveolar
     hemorrhage, nodules, interstitial disease and airway stenoses are the most common lung
     manifestations of antineutrophil cytoplasm antibody-associated vasculitides. Pulmonary
     vascular involvement also occurs in Behçet disease and Takayasu arteritis, where it
     manifests as pulmonary artery aneurysm, thrombosis and stenoses. Lung involvement
     usually occurs along with other systemic features of the vasculitis syndrome but can also
     be isolated leading to diagnostic and therapeutic challenges. Lung infection, pulmonary
     edema due to cardiac failure or renal impairment, cancer, and drug-induced lung toxicity
     are potential mimickers of pulmonary involvement in vasculitis. The management of lung
     disease in patients with vasculitis includes systemic and local therapies.

                                Introduction

     The lungs are affected by systemic vasculitides with differing frequency, characteristics
and severity, which vary by type of vasculitis in terms of involvement of the airways, lung
parenchyma, intraparenchymal proximal pulmonary arteries and veins, small capillary vessels
and pleura. These lung manifestations can be clinically silent or life-threatening, as with
diffuse alveolar hemorrhage. They can occur with other systemic manifestations of vasculitis

? Corresponding Author: Dr. Christian Pagnoux, Mount Sinai Hospital, Division of Rheumatology – Vasculitis
      clinic, Room 2-220, 60 Murray Street, Toronto, ON, M5T 3L9, Canada. Email: [email protected]

            Complimentary Contributor Copy
   262   263   264   265   266   267   268   269   270   271   272